All In Biotech

Drugs by condition

Drugs approved for fungal infections

Brand-name prescription drugs and biologics whose FDA label lists fungal infections as an approved use. Matched on the label phrases: "candidiasis", "aspergillosis".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

22

Still marketed, NDA or BLA

Drug classes

4

Novel drugs

8

New molecular entities and new biologics

In development

4

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for fungal infections.

All approved drugs for fungal infections, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 132 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Azole Antifungal (12)

  • Vivjoa Oteseconazole · Mycovia Pharms · 2022
  • Noxafil Posaconazole · Schering · 2006
  • Vfend Voriconazole · Pf Prism Cv · 2002
  • Sporanox Itraconazole · Janssen Pharms · 1992
  • Noxafil Powdermix Kit Posaconazole · Msd Merck CO · 2021
  • Tolsura Itraconazole · Mayne Pharma · 2018
  • Voriconazole Voriconazole · Hikma · 2017
  • Oravig Miconazole · Galt Pharms · 2010
  • Terconazole Terconazole · Fougera · 2004
  • Vfend Voriconazole · Pf Prism Cv · 2003
  • Vfend Voriconazole · Pf Prism Cv · 2002
  • Diflucan Fluconazole · Pfizer · 1993

Echinocandin Antifungal (2)

  • Rezzayo Rezafungin Acetate · Mundipharma · 2023
  • Eraxis Anidulafungin · Vicuron Holdings · 2006

Nucleoside Analog Antifungal (1)

  • Ancobon Flucytosine · Bausch · 1971

Class not listed in FDA's data (7)

Drugs in development for fungal infections

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • FosmanogepixPhase 32 trials

    Basilea Pharmaceutica · Candidemia, Candidiasis, Invasive, Invasive Mold Infections

  • OlorofimF901318Phase 32 trials

    F2G Ltd · Coccidioidomycosis, Disseminated Fungal Infection, Coccidioides Infection

  • TMPSMX, Trimethoprim-sulfamethoxazolePhase 32 trials

    Locus Biosciences · Urinary Tract Infections, Candidemia, Mycoses

  • HRS9432Phase 21 trial

    Fujian Shengdi Pharmaceutical Co., Ltd. · Patients With Candidemia and/or Invasive Candidiasis

3 discontinued brand-name drugs whose label still names it

More on fungal infections: recruiting trials · published research

Related in infectious disease and vaccines: HIV · Hepatitis B · Hepatitis C · COVID-19 · Influenza · RSV · Urinary tract infection · Pneumonia · Skin infections · C. difficile infection

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.